Akhteruzzaman Molla

5.9k citations

85 papers · 4.6k indexed · 1 hit paper · h-index 38

Infectious Diseases top 0.5%
Virology top 0.5%
Molecular Biology top 10%
Epidemiology top 2%
Hepatology top 0.5%

Co-authors: Eckard Wimmer Aniko V. Paul Dale J. Kempf Hongmei Mo Hiroshi Maeda John M. Leonard Warren M. Kati Daniel W. Norbeck
Topics: HIV/AIDS drug development and treatment (43 papers)Hepatitis C virus research (31 papers)HIV Research and Treatment (23 papers)
Cited by: Virology Hepatology Infectious Diseases
Journals: Nature Science Journal of Biological Chemistry
Partner nations: United States United Kingdom Japan

In The Last Decade

Akhteruzzaman Molla

84 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1996 601 citations Akhteruzzaman Molla, Marina Korneyeva et al. Nature Medicine profile →

Peers

Countries citing papers authored by Akhteruzzaman Molla

Since Specialization

Citations

This map shows the geographic impact of Akhteruzzaman Molla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akhteruzzaman Molla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akhteruzzaman Molla more than expected).

Fields of papers citing papers by Akhteruzzaman Molla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akhteruzzaman Molla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akhteruzzaman Molla. The network helps show where Akhteruzzaman Molla may publish in the future.

Co-authorship network of co-authors of Akhteruzzaman Molla

This figure shows the co-authorship network connecting the top 25 collaborators of Akhteruzzaman Molla. A scholar is included among the top collaborators of Akhteruzzaman Molla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akhteruzzaman Molla. Akhteruzzaman Molla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymerase 2012 ·Bioorganic & Medicinal Chemistry Letters ·Yaya Liu,(unknown),(unknown),Charles A. Flentge,Douglas K. Hutchinson,Darold L. Madigan,John T. Randolph,Rolf Wagner,Clarence J. Maring,Warren M. Kati,Akhteruzzaman Molla	20
2	Pseurotin A: an antibacterial secondary metabolite from Aspergillus fumigatus. 2010 ·Asian Journal of Chemistry ·(unknown),Akhteruzzaman Molla,Proma Khondkar,(unknown),Md Aminul Islam,(unknown),Rasheduzzaman Chowdhury	19
3	Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well 2009 ·Antiviral Research ·Rubina Mondal,Gennadiy Koev,Edward Tam,Yupeng He,Teresa I. Ng,Warren M. Kati,Akhteruzzaman Molla	14
4	Identification of halosalicylamide derivatives as a novel class of allosteric inhibitors of HCV NS5B polymerase 2008 ·Bioorganic & Medicinal Chemistry Letters ·Yaya Liu,(unknown),John K. Pratt,(unknown),Teresa I. Ng,Vijaya Gracias,(unknown),Paul E. Wiedeman,Linda Traphagen,Usha Warrior,Clarence J. Maring,Warren M. Kati,Stevan W. Djurić,Akhteruzzaman Molla	13
5	Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology 2007 ·Hepatology ·Teresa I. Ng,Hongmei Mo,Edward Tam,Yupeng He,Gennadiy Koev,Preethi Krishnan,Rubina Mondal,Ron Pithawalla,Wenping He,(unknown),Jeremy C.L. Packer,Mark E. Schurdak,Akhteruzzaman Molla	105
6	A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations 2007 ·Journal of Virological Methods ·Tim Middleton,Yupeng He,Edward Tam,Rakesh Tripathi,(unknown),Andrew Roth,Chih‐Ming Chen,Gennadiy Koev,Teresa I. Ng,Preethi Krishnan,Ron Pithawalla,Rubina Mondal,Tatyana Dekhtyar,Liangjun Lu,Hongmei Mo,Warren M. Kati,Akhteruzzaman Molla	25
7	Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro 2006 ·Antiviral Research ·Gennadiy Koev,Tatyana Dekhtyar,(unknown),Ping Yan,Teresa I. Ng,(unknown),Hongmei Mo,Akhteruzzaman Molla	24
8	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd W. Rockway,Rong Zhang,Dachun Liu,David A. Betebenner,Keith F. McDaniel,John K. Pratt,David W. A. Beno,Debra Montgomery,(unknown),Sherie Masse,Warren M. Kati,Tim Middleton,Akhteruzzaman Molla,Clarence J. Maring,Dale J. Kempf	22
9	Replication efficiency of chimeric replicon containing NS5A–5B genes derived from HCV-infected patient sera 2006 ·Antiviral Research ·Rakesh Tripathi,Preethi Krishnan,Yupeng He,Tim Middleton,Edward Tam,Chih‐Ming Chen,Daryl Lau,Stanley M. Lemon,Hongmei Mo,Warren M. Kati,Akhteruzzaman Molla	27
10	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger,Darold L. Madigan,Wen Jiang,Warren M. Kati,Dachun Liu,Yaya Liu,Clarence J. Maring,Sherie Masse,Keith F. McDaniel,Tim Middleton,Hongmei Mo,Akhteruzzaman Molla,Debra Montgomery,John K. Pratt,Todd W. Rockway,Rong Zhang,Dale J. Kempf	24
11	Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors 2006 ·Bioorganic & Medicinal Chemistry ·John T. Randolph,Peggy Huang,(unknown),David A. DeGoey,Larry L. Klein,Clinton M. Yeung,Charles A. Flentge,(unknown),Chen Zhao,Tatyana Dekhtyar,Hongmei Mo,(unknown),Warren M. Kati,Kennan C. Marsh,Akhteruzzaman Molla,Dale J. Kempf	10
12	Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines 2005 ·Bioorganic & Medicinal Chemistry Letters ·John K. Pratt,(unknown),Keith F. McDaniel,Clarence J. Maring,Warren M. Kati,Hongmei Mo,Tim Middleton,Yaya Liu,Teresa I. Ng,(unknown),Rong Zhang,Debra Montgomery,Akhteruzzaman Molla,Dale J. Kempf,William E. Kohlbrenner	28
13	Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction 2004 ·Virology ·Hongmei Mo,Alex K. Konstantinidis,Kent D. Stewart,Tatyana Dekhtyar,Teresa I. Ng,Kerry M. Swift,Edmund D. Matayoshi,Warren M. Kati,William E. Kohlbrenner,Akhteruzzaman Molla	38
14	Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavir 2003 ·Antiviral Research ·Hongmei Mo,Liangjun Lu,Tatyana Dekhtyar,Kent D. Stewart,Eugene Sun,Dale J. Kempf,Akhteruzzaman Molla	27
15	Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus 1998 ·Virology ·Akhteruzzaman Molla,Sudthida Vasavanonda,Gondi Kumar,Hing L. Sham,(unknown),Brian Grabowski,Jon F. Denissen,William E. Kohlbrenner,Jacob J. Plattner,John M. Leonard,Daniel W. Norbeck,Dale J. Kempf	154
16	Ordered accumulation of mutations in HIV protease confers resistance to ritonavirbreakdown → 1996 ·Nature Medicine ·Akhteruzzaman Molla,Marina Korneyeva,Qing Gao,Sudthida Vasavanonda,(unknown),Hongmei Mo,Martin Markowitz,(unknown),Ping Niu,Nicholas A. Lyons,Ann Hsu,G. Richard Granneman,David D. Ho,Charles A. Boucher,John M. Leonard,Daniel W. Norbeck,Dale J. Kempf	601
17	Studies of a Putative Amphipathic Helix in the N-Terminus of Poliovirus Protein 2C 1994 ·Virology ·Aniko V. Paul,Akhteruzzaman Molla,(unknown)	69
18	Cardioviral internal ribosomal entry site is functional in a genetically engineered dicistronic poliovirus 1992 ·Nature ·Akhteruzzaman Molla,Sung Key Jang,Aniko V. Paul,(unknown),Eckard Wimmer	110
19	Pathogenic potentials of bacterial proteases 1989 ·Clinica Chimica Acta ·Hiroshi Maeda,Akhteruzzaman Molla	54
20	Interdomain cleavage of plasma fibronectin by zinc-metalloproteinase from Serratia marcescens 1988 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Akhteruzzaman Molla,Sumio Tanase,Yeong-Man Hong,Hiroshi Maeda	20

About Akhteruzzaman Molla

Akhteruzzaman Molla is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 85 papers that have together received 4.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (43 papers), Hepatitis C virus research (31 papers) and HIV Research and Treatment (23 papers). The work is most often cited by research in Virology (1.4k citations), Hepatology (1.1k citations) and Infectious Diseases (2.4k citations). Akhteruzzaman Molla has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Eckard Wimmer, Aniko V. Paul, Dale J. Kempf, Hongmei Mo, Hiroshi Maeda, John M. Leonard, Warren M. Kati, Daniel W. Norbeck, G. Richard Granneman and Sudthida Vasavanonda. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact